NCT00019539View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1998

Study Completion Date

November 30, 2004

Conditions
Stage IV Renal Cell CancerRecurrent Renal Cell Cancer
Interventions
DRUG

bevacizumab

DRUG

thalidomide

Trial Locations (1)

20892

Surgery Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019539 - Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer | Biotech Hunter | Biotech Hunter